Pharmacy Department, Vall d'Hebron University Hospital, Passeig Vall Hebron 119-129, Barcelona, Spain.
Pharmacy Department, Vall d'Hebron University Hospital, Passeig Vall Hebron 119-129, Barcelona, Spain.
Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:106-109. doi: 10.1016/j.ejogrb.2022.06.006. Epub 2022 Jun 20.
The physical compatibility of atosiban and selected drugs during simulated Y-site administration was evaluated. We also searched for any compatibility predictions regarding its physicochemical properties.
Test admixtures were prepared by mixing 5 mL of each study drug solution with 5 mL of atosiban solution in a 1:1 ratio to simulate Y-site infusion. Assessments were made immediately after mixing (baseline), and at 0.5, 1, and 3 h. Visual incompatibility was defined as a presence of haze or any visible particulate matter, gas formation, or colour change. Turbidity and pH variation of the admixtures were also assessed using instrumental methods.
None of the admixtures used with atosiban exhibited visual changes and no incompatibility regarding instrumental methods were observed, because no admixture had an increase of 0.5 nephelometric turbidity units, and no pH change was above one unit when compared to baseline. However, the pH of ampicillin and omeprazole admixtures fell outside of the atosiban stability range.
Our study showed no physical incompatibility between atosiban and the test drugs in terms of visual changes or nephelometric and pH measurements. However, we recommend against atosiban and ampicillin or omeprazole coadministration until complementary compatibility studies are performed.
评估阿托西班与选定药物在模拟 Y 型部位给药时的物理相容性。我们还搜索了其物理化学性质的任何相容性预测。
通过将每种研究药物溶液的 5 mL 与阿托西班溶液的 5 mL 以 1:1 的比例混合来制备测试混合物,以模拟 Y 型部位输注。在混合后立即(基线)以及 0.5、1 和 3 h 进行评估。视觉不兼容性定义为存在浊度或任何可见的颗粒物质、气体形成或颜色变化。还使用仪器方法评估混合物的浊度和 pH 变化。
与阿托西班一起使用的所有混合物均未显示视觉变化,也未观察到仪器方法的不兼容性,因为没有混合物的浊度增加超过 0.5 奈氏单位,并且与基线相比,pH 变化不超过一个单位。然而,氨苄西林和奥美拉唑混合物的 pH 值超出了阿托西班的稳定范围。
我们的研究表明,阿托西班与测试药物在视觉变化或浊度和 pH 测量方面没有物理不兼容性。然而,我们建议在进行互补相容性研究之前,避免阿托西班与氨苄西林或奥美拉唑联合使用。